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The functions of Poly(ADP-ribose) polymerase enzymes
(PARPs) in general are best studied based on human
PARP-1 (HsPARP-1). HsPARP-1 is well investigated
because pharmacological modulation of its activity mod-
ulates DNA-binding of antitumor drugs [1]. In contrast
to human PARP enzymes, the exact role of PARPs in
plants remains to be elucidated. Different stresses acti-
vate plant PARP enzymes to mediate DNA repair and
(programmed) cell death whereas the addition of PARP
inhibitors decreases the degree of cell death [2]. There-
fore, the development of plant PARP inhibitors might
be a way to increase the tolerance against abiotic stress.
Initial to searches in commercial databases for potential
plant PARP inhibitors, a virtual screening route had to be
established for human PARP-1 inhibitors. Simultaneously,
every step in that procedure was applied on a plant PARP
enzyme to investigate the differences of both active sites.
All differences have been evaluated statistically, e.g. using
receiver-operator characteristics (ROC) and power ana-
lyses. At the end of that parallel screening route, a docking
threshold for Arabidopsis thaliana L. PARP-1 (AtPARP-1)
could be derived by knowledge transfer from the corre-
sponding human receptor and its inhibitors.
Knowing the differences of the human and plant
screening routes, predictions of the applicability of that
multi-step process on a commercial database have been
explored. Finally, the developed virtual screening route
has been applied to screen a commercial database for
AtPARP-1 inhibitors. From 20 compounds tested so far
in vitro, 13 show inhibitory effects.
Author details
1Leibniz-Institute for Plant Biochemistry, Halle, 06114, Germany.
2Agrochemical Institute Piesteritz e.V. (AIP), Wittenberg, 06886, Germany.
Published: 1 May 2012
References
1. Ferraris D: Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1)
Inhibitors. From Concept to Clinic. J Med Chem 2010, 53:4561-4584.
2. DeBlock M: Poly(ADP-ribose) polymerase in plants affects energy
homeostasis, cell death and stress tolerance. The Plant Journal 2005,
41:95-106.
doi:10.1186/1758-2946-4-S1-O24
Cite this article as: Heym et al.: Virtual screening for plant PARP
inhibitors – what can be learned from human PARP inhibitors? Journal
of Cheminformatics 2012 4(Suppl 1):O24.
1Leibniz-Institute for Plant Biochemistry, Halle, 06114, Germany
Full list of author information is available at the end of the article
Figure 1 Key steps in virtual screening routes for human and Arabidopsis thaliana L. PARP-1. The results have been used to successfully apply
the screening process for AtPARP-1 on a commercial database.
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